> The FDA has approved Natco's anti-cancer drug Ondansetron Hydrochloride tablets in multiple strengths. Report
> The Dutch company Clinquest has acquired a stake in Enceladus and has led a syndicate of investors to provide additional funding. Financial details were not disclosed. Release
> GPC Biotech announced that its partner, Pharmion, has submitted an MMA to the European Medicines Agency for satraplatin in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer who have failed prior chemotherapy. Release
> UCB and Biogen Idec announced the initiation of a Phase II study of CDP323--an oral VLA-4 antagonist--under development for relapsing-remitting multiple sclerosis. Release
> The FDA is allowing Allergan to change the label for Juvederm to indicate that the wrinkle filler lasts longer than had previously been thought. Release
> The UK's Intercytex has unveiled new early-stage data that supports its contention that an experimental artificial skin can reduce scarring. Report
And Finally... Disgraced scientist Hwang Woo-suk is back at work on cloned embryos. Report